Evelo Biosciences Inc (EVLO)
OTHER OTC:EVLO
US Market
Holding EVLO?
Track your performance easily

Evelo Biosciences (EVLO) Income Statement

214 Followers

Evelo Biosciences Income Statement

Last quarter (Q3 2023), Evelo Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Evelo Biosciences's net income was $-12.36M. See Evelo Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
----$ 500.00K$ 200.00K
Cost of Revenue
------
Gross Profit
----$ 500.00K$ 200.00K
Operating Expense
$ 76.74M$ 108.47M$ 115.40M$ 91.89M$ -86.36M$ -58.10M
Operating Income
$ -76.74M$ -108.47M$ -115.40M$ -91.89M$ -86.36M$ -58.10M
Net Non Operating Interest Income Expense
$ -1.30M$ 4.67M--$ 1.05M$ 1.56M
Other Income Expense
$ -2.27M$ -459.00K$ 6.35M$ 1.37M$ -26.00K$ 406.00K
Pretax Income
$ -81.44M$ -113.60M$ -121.75M$ -93.26M$ -85.28M$ -56.95M
Tax Provision
$ -397.00K$ 930.00K$ 428.00K$ 409.00K$ 200.00K-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -82.35M$ -114.53M$ -122.18M$ -93.67M$ -85.48M$ -60.88M
Basic EPS
$ -9.15$ -1.31$ -46.20$ -47.40--
Diluted EPS
$ -9.15$ -1.31$ -46.20$ -47.40$ -53.40$ -55.60
Basic Average Shares
$ 139.79M$ 87.17M$ 2.65M$ 1.97M$ 1.60M$ 1.09M
Diluted Average Shares
$ 139.79M$ 87.17M$ 2.65M$ 1.97M$ 1.60M$ 1.02M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 76.74M$ 108.47M$ 115.40M$ 91.89M$ -86.36M$ -58.10M
Net Income From Continuing And Discontinued Operation
$ -82.35M$ -114.53M$ -122.18M$ -93.67M$ -85.48M$ -56.95M
Normalized Income
$ -48.14M$ -89.74M$ -96.18M---
Interest Expense
------
EBIT
$ -77.80M$ -108.92M$ -118.14M$ -91.15M$ -85.28M$ -56.95M
EBITDA
$ -76.20M$ -106.86M$ -115.92M$ -89.12M$ -83.65M$ -55.05M
Currency in USD

Evelo Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis